The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Disruptor Profile: Pear Therapeutics, Inc.

Disruptor Profile: Pear Therapeutics, Inc.

Publishing Date : Jun, 2019

License Type :
 

Report Code : 1533004

No of Pages : 11

Synopsis
Disruptor Profile: Pear Therapeutics, Inc.

Summary

The report provides information and insights into Pear Therapeutics, Inc.'s, including -
- Overview of the company and its product offering
- Detailed insight into its business model, company type and headquarter
- Information on partnership and funding
- Biography of top management.

Scope

- Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.

Reasons to buy

- Gain insights into Pears’s business operations.
- Gain insights into funding and partnerships
- Gain understanding about its technology focus.

Companies Mentioned
Sandoz
Novartis
EDBI Pte Ltd
Blue Water Life Science Fund LP
Bridge Builders Collaborative
5AM Venture Management LLC
Novartis AG
TrustBridge Partners
Arboretum Ventures LLC
Temasek Holdings (Private) Ltd
JAZZ Venture Partners L.P.

Geographical Area
Global
Index
Table of contents
Company Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix

Published By : GlobalData

Why ‘The Market Reports’